Merck
We aspire to be the premier research-intensive biopharmaceutical company. We’re at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.
PI diagnosis sparks PhD candidate’s neuroimmunology research interest
February 09, 2024
Read article
Adulting with PI support group leader specializes in trauma
January 31, 2024
Read article
Complement deficiencies
January 30, 2024
Watch video
Decoding antibody deficiency diagnoses
January 25, 2024
Read article
Strategic Plan 2024-2026
January 25, 2024
View PDF
Bill of Rights for individuals with primary immunodeficiencies
January 25, 2024
View PDF
Addressing accessibility of gene and cell therapies
January 24, 2024
View PDF
Parents push Medicaid to cover four-year-old’s thymus tissue implant
January 23, 2024
Read article
2023 Community Impact flyer
January 16, 2024
View PDF
